Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells

Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy

NCT01000246 ·Status: COMPLETED ·Phase: NA

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

NCT00197288 ·Status: COMPLETED ·Phase: PHASE3

Proteomic Profiling for Influenza Vaccination - FluMist

NCT00385281 ·Status: COMPLETED ·Phase: PHASE4

A/H5N1in Adult - Aventis

NCT00115986 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults

NCT00942071 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Assess the Safety of a New Influenza Vaccine

NCT01104493 ·Status: COMPLETED ·Phase: PHASE4

Optimizing Influenza Vaccination in Surgical Oncology Patients

NCT01698177 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

NCT01465035 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

NCT00240877 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1

NCT01818362 ·Status: COMPLETED ·Phase: PHASE1

Response to Influenza Vaccination in Pediatric Oncology Patients

NCT05384288 ·Status: RECRUITING

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

NCT01031719 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity Study of the Influenza Vaccine in Adults

NCT00258934 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

NCT00630331 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

NCT01640314 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

NCT07349017 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

NCT03158038 ·Status: COMPLETED ·Phase: PHASE4

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

NCT00216242 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

NCT00973349 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults

NCT00993083 ·Status: COMPLETED ·Phase: PHASE2

Trial to Describe the Safety and Immunogenicity of Fluzone®

NCT00524940 ·Status: COMPLETED ·Phase: PHASE2

H5N1 Mix and Match With MF59

NCT01317745 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

NCT00644059 ·Status: COMPLETED ·Phase: PHASE3

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

NCT03590808 ·Status: COMPLETED ·Phase: NA

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

NCT00539981 ·Status: COMPLETED ·Phase: PHASE3